This session explores how pharma companies approach and build effective partnerships with computational drug discovery firms. Industry experts will share insights on best practices for data sharing, strategies for navigating cultural challenges with AI-driven startups, and the role of explainable AI in fostering trust. The discussion will also cover common mistakes AI biotech companies make when approaching pharma and the considerations around using proprietary algorithms versus open-source models to advance drug discovery.